drug development
Danaher Launches US, UK Laboratories for Precision Medicine Test Development
The CLIA- and CAP-certified laboratories are intended to accelerate the development of companion diagnostics and complementary diagnostics.
At the ASGCT annual meeting, Marks outlined the agency's thinking on accelerated approvals and when market withdrawals may be needed.
Nucleai Raises $14M in Funding Round Led by Merck KGaA's M Ventures
The company said it will use the funds to further apply its AI algorithms in the prospective enrollment of patients in clinical trials.
After Proof-of-Concept, Resolution Therapeutics' Liver Cirrhosis Cell Therapy to Enter Phase I/II
Premium
Data on a non-engineered version of the macrophage cell therapy has given the Edinburgh spinout confidence as it moves forward with an engineered version.
Grace Science to Start Phase I/II/III Trial for Gene Therapy in NGLY1 Deficiency
The firm will begin enrolling pediatric patients with the debilitating neurological disease into the open-label, single-arm study.
Nov 7, 2023
Nov 1, 2023
Sep 28, 2023
Sep 25, 2023